Mounjaro for Sleep Apnoea – Weight Management Support Guide
14 February 2026 · 3 min read
Introduction
Obstructive sleep apnoea (OSA) is strongly associated with overweight and obesity.
Excess weight, particularly around the neck and upper airway, can increase airway obstruction during sleep.
Weight reduction is commonly recommended as part of sleep apnoea management.
Mounjaro (tirzepatide) is not a treatment for sleep apnoea itself, but it may be prescribed for weight management in suitable adults following medical review.
If you would like to explore treatment suitability, you can start your online Mounjaro consultation
This guide explains:
- What sleep apnoea is
- How weight affects airway obstruction
- How Mounjaro works
- Safety considerations
What Is Obstructive Sleep Apnoea?
Obstructive sleep apnoea occurs when:
- The airway collapses during sleep
- Breathing temporarily stops
- Oxygen levels fluctuate
- Sleep becomes fragmented
Symptoms may include:
- Loud snoring
- Daytime fatigue
- Morning headaches
- Poor concentration
OSA is often linked to excess body weight.
For a full overview of Mounjaro:
Why Weight Loss Matters in Sleep Apnoea
Weight reduction may help:
- Reduce fat around the airway
- Improve breathing mechanics
- Lower apnoea severity
- Reduce cardiometabolic risk
Structured weight management is often recommended alongside CPAP therapy where appropriate.
GLP-1 pathway medications support appetite regulation and calorie reduction.
For dosing details:
How Mounjaro Works in Weight Management
Mounjaro activates:
- GLP-1 receptors
- GIP receptors
These pathways influence:
- Appetite suppression
- Satiety
- Calorie intake
- Glycaemic control
By supporting sustained weight reduction, it may indirectly benefit weight-related contributors to sleep apnoea.
For insulin resistance context:
Mounjaro for insulin resistance
Is Mounjaro Licensed for Sleep Apnoea?
Mounjaro is not licensed as a sleep apnoea treatment.
It is licensed for weight management and defined metabolic indications.
Prescribing decisions are based on:
- BMI
- Medical history
- Cardiovascular risk
- Overall health assessment
To check eligibility:
complete your consultation online
Safety Considerations
Before prescribing, clinicians review:
- Cardiovascular history
- Blood pressure
- Diabetes status
- Current medications
Weight reduction in individuals with sleep apnoea should be medically supervised.
For safety information:
What Dose Is Used?
Treatment usually begins at:
2.5mg weekly for 4 weeks
Followed by gradual escalation if tolerated.
For starter dose details:
Escalation depends on response and tolerability.
Cost of Mounjaro for Sleep Apnoea (UK Private)
Private pricing at PPRX:
- 2.5mg — £194.99
- 5mg — £214.99
- 7.5mg — £274.99
- 10mg — £304.99
- 12.5mg — £324.99
- 15mg — £349.99
For full breakdown:
Pricing includes prescription, delivery and pharmacist support.
To order safely:
Who May Be Suitable?
Mounjaro may be considered for adults who:
- Have obstructive sleep apnoea
- Have overweight or obesity
- Have struggled with appetite regulation
- Are seeking structured weight management
Suitability is determined through structured medical screening.
To begin assessment:
start your online consultation
FAQ – Mounjaro for Sleep Apnoea
Does Mounjaro treat sleep apnoea?
No. It supports weight management.
Can weight loss improve sleep apnoea?
Weight reduction may reduce severity in some individuals.
Is it safe with CPAP therapy?
Medical review is required.
Is it licensed for sleep apnoea?
No, it is licensed for weight management.
Can I order online?
Yes, following prescriber approval.
📞 Get in Touch
Visit www.pprx.co.uk or contact us directly to begin your online consultation.
We offer fast, discreet UK-wide delivery and exceptional support throughout your journey.
Mounjaro is a prescription-only medicine. This article is for informational purposes only and does not replace medical advice. Always consult a qualified healthcare provider before starting treatment. nhs